Background. Quinolinic acid phosphoribosyltransferase (QPRT) is a rate-limiting enzyme that encodes the uronic acid pathway, which is involved in cell cycle progression and cancer cell metabolism. Some studies have demonstrated the progrowth effect of QPRT on breast cancer (BRCA) tumour cells, but its mechanism of action requires further exploration. Methods. We investigated the expression of QPRT and the prognosis of patients with different tumours by performing a pan-cancer analysis of QPRT. Prognostic values for overall survival (OS) were determined using uni- and multivariate Cox proportional hazard analyses. The prognostic survival of patients with a different pathological staging of BRCA and with QPRT high and low expression was also analysed. We also explored the relevant pathways by which QPRT affected BRCA tumorigenesis by gene set enrichment analysis (GSEA) and western blotting. The impact of QPRT on the PI3K/Akt pathway was also evaluated. Results. Pan-cancer analysis revealed significant QPRT expression in pan-cancer and correlated with prognosis in most tumour patients. QPRT was also highly expressed in BRCA when patients had poor prognoses, and its expression was associated with different pathological BRCA subtypes. GSEA revealed an association between BRCA progression and the cell cycle and the phosphatidylinositol 3-kinase (PI3K)/Akt signalling pathway, and this association was confirmed by western blotting. Conclusion. QPRT is highly expressed in breast cancer and particularly in HER2 breast cancer. Upregulated QPRT expression is an independent predictor of breast cancer prognosis and promotes breast cancer progression by activating the PI3K/Akt signalling pathway.
18 October 2023 in Journal of Cellular and Molecular Medicine
To develop and validate the predictive effects of stable ferroptosis‐ and pyroptosis‐related features on the prognosis and immune status of breast cancer (BC). We retrieved as well as downloaded ferroptosis‐ and pyroptosis‐related genes from the FerrDb and GeneCards databases. The minimum absolute contraction and selection operator (LASSO) algorithm in The Cancer Genome Atlas (TCGA) was used to construct a prognostic classifier combining the above two types of prognostic genes with differential expression, and the Integrated Gene Expression (GEO) dataset was used for validation. Seventeen genes presented a close association with BC prognosis. Thirteen key prognostic genes with prognostic value were considered to construct a new expression signature for classifying patients with BC into high‐ and low‐risk groups. Kaplan–Meier analysis revealed a worse prognosis in the high‐risk group. The receiver operating characteristic (ROC) curve and multivariate Cox regression analysis identified its predictive and independent features. Immune profile analysis showed that immunosuppressive cells were upregulated in the high‐risk group, and this risk model was related to immunosuppressive molecules. We successfully constructed combined features of ferroptosis and pyroptosis in BC that are closely related to prognosis, clinicopathological and immune features, chemotherapy efficacy and immunosuppressive molecules. However, further experimental studies are required to verify these findings.
Large-scale fine-tuning produced a highly accurate large language model for automated radiology impression generation, demonstrating a validated approach to improve reporting efficiency and consistency across multicenter examinations.
30 November 2023 in Chinese Journal of Academic Radiology
Myocardial scar is a critical pathological substrate, often identified using cardiac magnetic resonance (CMR) as the gold standard. However, CMR accessibility is limited by cost, time, and expertise requirements. This study aimed to develop an artificial intelligence (AI)-powered dual-sequence computed tomography (CT) framework integrating coronary CT angiography (CCTA) and coronary artery calcium (CAC) for detecting myocardial scar, using CMR as the reference. We retrospectively included patients who underwent CCTA, CAC, and CMR. A deep learning nnU-Net model enabled automated cardiac segmentation and rule-based subdivision following the American Heart Association 17-segment model. Radiomic features were extracted from CCTA and CAC, along with volumetric indices, stenosis grading, and clinical/echocardiographic variables. A total of 533 patients were included. CCTA radiomics achieved an AUC of 0.85 at the patient level. Dual-sequence analyses were performed in 257 patients. In this subcohort, the integrated CT model achieved 0.87 and the multimodal model combining CT, clinical, and echocardiographic features achieved an AUC of 0.91. At the segmental level, the combined CCTA-CAC model yielded an AUC of 0.80 among patients with CMR-confirmed myocardial scar. AI-derived dual-sequence CT features demonstrated good discriminatory performance for detecting myocardial scar at the patient level and identifying scar-positive regions at the segmental level. By integrating CT features with clinical and echocardiographic variables, the multimodal model achieved favorable patient-level performance. These findings support the potential role of the proposed CT-based framework in providing complementary scar-related information and identifying high-risk patients who may benefit from further CMR evaluation in appropriate clinical settings.